요약정보
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia.
- Resource Type
- Academic Journal
- Authors
- Alshamleh I; Center for Biomolecular Magnetic Resonance (BMRZ), Institute of Organic Chemistry and Chemical Biology, Goethe University Frankfurt, 60438, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Kurrle N; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Makowka P; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Bhayadia R; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Department of Pediatrics, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Kumar R; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.; Süsser S; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Seibert M; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Ludig D; Center for Biomolecular Magnetic Resonance (BMRZ), Institute of Organic Chemistry and Chemical Biology, Goethe University Frankfurt, 60438, Frankfurt am Main, Germany.; Wolf S; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Koschade SE; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Stoschek K; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Kreitz J; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Fuhrmann DC; Institute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, 60590, Frankfurt am Main, Germany.; Toenges R; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Notaro M; enGene Statistics GmbH, Basel, Switzerland.; Comoglio F; enGene Statistics GmbH, Basel, Switzerland.; Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Berg T; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Centre for Discovery in Cancer Research and Department of Oncology, McMaster University, Hamilton, ON, Canada.; Brüne B; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Institute of Biochemistry I, Faculty of Medicine, Goethe University Frankfurt, 60590, Frankfurt am Main, Germany.; Project Group Translational Medicine and Pharmacology TMP, Fraunhofer Institute for Molecular Biology and Applied Ecology, 60596, Frankfurt am Main, Germany.; Krause DS; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596, Frankfurt am Main, Germany.; Georg-Speyer-Haus; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Klusmann JH; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Department of Pediatrics, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Oellerich T; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany.; Schnütgen F; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany. schnuetgen@em.uni-frankfurt.de.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany. schnuetgen@em.uni-frankfurt.de.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany. schnuetgen@em.uni-frankfurt.de.; Schwalbe H; Center for Biomolecular Magnetic Resonance (BMRZ), Institute of Organic Chemistry and Chemical Biology, Goethe University Frankfurt, 60438, Frankfurt am Main, Germany. schwalbe@nmr.uni-frankfurt.de.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany. schwalbe@nmr.uni-frankfurt.de.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany. schwalbe@nmr.uni-frankfurt.de.; Serve H; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Hubert.Serve@kgu.de.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, 60590, Frankfurt, Germany. Hubert.Serve@kgu.de.; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596, Frankfurt, Germany. Hubert.Serve@kgu.de.
- Source
- Publisher:
Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN:08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE - Subject
- Language
- English